BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

881 related articles for article (PubMed ID: 30099957)

  • 1. Pulmonary arterial hypertension induced by a novel method: Twice-intraperitoneal injection of monocrotaline.
    Zhuang W; Lian G; Huang B; Du A; Xiao G; Gong J; Xu C; Wang H; Xie L
    Exp Biol Med (Maywood); 2018 Aug; 243(12):995-1003. PubMed ID: 30099957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 17β-estradiol preserves right ventricular function in rats with pulmonary arterial hypertension: an echocardiographic and histochemical study.
    Wang YD; Li YD; Ding XY; Wu XP; Li C; Guo DC; Shi YP; Lu XZ
    Int J Cardiovasc Imaging; 2019 Mar; 35(3):441-450. PubMed ID: 30350115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sulforaphane Improves Redox Homeostasis and Right Ventricular Contractility in a Model of Pulmonary Hypertension.
    Conzatti A; Colombo R; Siqueira R; Campos-Carraro C; Turck P; Luz de Castro A; Belló-Klein A; Sander da Rosa Araujo A
    J Cardiovasc Pharmacol; 2024 Jun; 83(6):612-620. PubMed ID: 38547510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pioglitazone alleviates cardiac and vascular remodelling and improves survival in monocrotaline induced pulmonary arterial hypertension.
    Behringer A; Trappiel M; Berghausen EM; Ten Freyhaus H; Wellnhofer E; Odenthal M; Blaschke F; Er F; Gassanov N; Rosenkranz S; Baldus S; Kappert K; Caglayan E
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Apr; 389(4):369-79. PubMed ID: 26742933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycyrrhizin, inhibitor of high mobility group box-1, attenuates monocrotaline-induced pulmonary hypertension and vascular remodeling in rats.
    Yang PS; Kim DH; Lee YJ; Lee SE; Kang WJ; Chang HJ; Shin JS
    Respir Res; 2014 Nov; 15():148. PubMed ID: 25420924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of estrogen on right ventricular remodeling of monocrotaline-induced pulmonary arterial hypertension in rats and its mechanism.
    Liu Z; Duan YL; Ge SL; Zhang CX; Gong WH; Xu JJ
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1742-1750. PubMed ID: 30840299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Glycoltic metabolism gene changes in left and right ventricles in experimental rat pulmonary arterial hypertension model].
    Qiu M; Zhang R; Zheng Y; Zhang W
    Zhonghua Xin Xue Guan Bing Za Zhi; 2014 Dec; 42(12):1010-6. PubMed ID: 25623347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-Aminosalicylic Acid Attenuates Monocrotaline-Induced Pulmonary Arterial Hypertension in Rats by Increasing the Expression of Nur77.
    Sun LY; Cai ZY; Pu J; Li J; Shen JY; Yang CD; He B
    Inflammation; 2017 Jun; 40(3):806-817. PubMed ID: 28213866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urantide improves the structure and function of right ventricle as determined by echocardiography in monocrotaline-induced pulmonary hypertension rat model.
    Wang Y; Tian W; Xiu C; Yan M; Wang S; Mei Y
    Clin Rheumatol; 2019 Jan; 38(1):29-35. PubMed ID: 29362961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perillyl alcohol suppresses monocrotaline-induced pulmonary arterial hypertension in rats via anti-remodeling, anti-oxidant, and anti-inflammatory effects.
    Beik A; Najafipour H; Joukar S; Rajabi S; Iranpour M; Kordestani Z
    Clin Exp Hypertens; 2021 Apr; 43(3):270-280. PubMed ID: 33322932
    [No Abstract]   [Full Text] [Related]  

  • 11. Preventive treatment with atorvastatin ameliorates endothelial dysfunction of small pulmonary arteries in monocrotaline-induced pulmonary hypertensive rats.
    Lin Z; Jiang Z; Huang X; Cai X; Wang H; Xie L
    Clin Exp Hypertens; 2017; 39(6):495-501. PubMed ID: 28628347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of inflammation process in monocrotaline-induced pulmonary arterial hypertension in rats.
    Tang C; Luo Y; Li S; Huang B; Xu S; Li L
    Biomed Pharmacother; 2021 Jan; 133():111081. PubMed ID: 33378977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preventive and remedial application of etanercept attenuate monocrotaline-induced pulmonary arterial hypertension.
    Zhang LL; Lu J; Li MT; Wang Q; Zeng XF
    Int J Rheum Dis; 2016 Feb; 19(2):192-8. PubMed ID: 24612527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PRX-08066, a novel 5-hydroxytryptamine receptor 2B antagonist, reduces monocrotaline-induced pulmonary arterial hypertension and right ventricular hypertrophy in rats.
    Porvasnik SL; Germain S; Embury J; Gannon KS; Jacques V; Murray J; Byrne BJ; Shacham S; Al-Mousily F
    J Pharmacol Exp Ther; 2010 Aug; 334(2):364-72. PubMed ID: 20430844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allogenic stem cell therapy improves right ventricular function by improving lung pathology in rats with pulmonary hypertension.
    Umar S; de Visser YP; Steendijk P; Schutte CI; Laghmani el H; Wagenaar GT; Bax WH; Mantikou E; Pijnappels DA; Atsma DE; Schalij MJ; van der Wall EE; van der Laarse A
    Am J Physiol Heart Circ Physiol; 2009 Nov; 297(5):H1606-16. PubMed ID: 19783775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathophysiology of infantile pulmonary arterial hypertension induced by monocrotaline.
    Dias-Neto M; Luísa-Neves A; Pinho S; Gonçalves N; Mendes M; Eloy C; Lopes JM; Gonçalves D; Ferreira-Pinto M; Leite-Moreira AF; Henriques-Coelho T
    Pediatr Cardiol; 2015 Jun; 36(5):1000-13. PubMed ID: 25608696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HMGB1 promotes the development of pulmonary arterial hypertension in rats.
    Sadamura-Takenaka Y; Ito T; Noma S; Oyama Y; Yamada S; Kawahara K; Inoue H; Maruyama I
    PLoS One; 2014; 9(7):e102482. PubMed ID: 25032709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary Artery Hypertension Model in Rats by Monocrotaline Administration.
    Bueno-Beti C; Sassi Y; Hajjar RJ; Hadri L
    Methods Mol Biol; 2018; 1816():233-241. PubMed ID: 29987824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early Intervention of Tongxinluo () on Right Ventricular Function Assessed by Echocardiography in Rats with Pulmonary Arterial Hypertension Induced by Monocrotaline.
    Gao L; Li SD; Zhang Y; Liu Y; Yang MH
    Chin J Integr Med; 2020 Dec; 26(12):913-920. PubMed ID: 32418178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ranolazine prevents INaL enhancement and blunts myocardial remodelling in a model of pulmonary hypertension.
    Rocchetti M; Sala L; Rizzetto R; Staszewsky LI; Alemanni M; Zambelli V; Russo I; Barile L; Cornaghi L; Altomare C; Ronchi C; Mostacciuolo G; Lucchetti J; Gobbi M; Latini R; Zaza A
    Cardiovasc Res; 2014 Oct; 104(1):37-48. PubMed ID: 25139747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.